These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20713858)

  • 1. Effectiveness and safety of tocilizumab, an anti-interleukin-6 receptor monoclonal antibody, in a patient with refractory GI graft-versus-host disease.
    Gergis U; Arnason J; Yantiss R; Shore T; Wissa U; Feldman E; Woodworth T
    J Clin Oncol; 2010 Oct; 28(30):e602-4. PubMed ID: 20713858
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful use of Campath-1H in the treatment of steroid refractory liver GvHD.
    Wandroo F; Auguston B; Cook M; Craddock C; Mahendra P
    Bone Marrow Transplant; 2004 Aug; 34(3):285-7. PubMed ID: 15170160
    [No Abstract]   [Full Text] [Related]  

  • 3. Effective use of tocilizumab for the treatment of steroid-refractory gastrointestinal acute graft versus host disease in a child with very high levels of serum interleukin-6.
    Kolb M; Bhatia M; Madina GG; Satwani P
    Pediatr Blood Cancer; 2015 Feb; 62(2):362-363. PubMed ID: 25212196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tocilizumab for steroid refractory acute graft-versus-host disease.
    Roddy JV; Haverkos BM; McBride A; Leininger KM; Jaglowski S; Penza S; Klisovic R; Blum W; Vasu S; Hofmeister CC; Benson DM; Andritsos LA; Devine SM; Efebera YA
    Leuk Lymphoma; 2016; 57(1):81-5. PubMed ID: 26140610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Encouraging results with inolimomab (anti-IL-2 receptor) as treatment for refractory acute graft-versus-host disease.
    Piñana JL; Valcárcel D; Martino R; Moreno ME; Sureda A; Briones J; Brunet S; Sierra J
    Biol Blood Marrow Transplant; 2006 Nov; 12(11):1135-41. PubMed ID: 17085306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humanized anti-CD25 monoclonal antibody treatment of steroid-refractory acute graft-versus-host disease: a Chinese single-center experience in a group of 64 patients.
    Tao T; Ma X; Yang J; Zou JY; Ji SM; Tan YS; Gong W; Du F; Xu J; Ye CM; Tang XW; Wu DP; Xue SL
    Blood Cancer J; 2015 Apr; 5(4):e308. PubMed ID: 25885428
    [No Abstract]   [Full Text] [Related]  

  • 7. B-cell involvement in chronic graft-versus-host disease.
    Kapur R; Ebeling S; Hagenbeek A
    Haematologica; 2008 Nov; 93(11):1702-11. PubMed ID: 18728020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Friends, faithfulness and fortunes.
    Hale G
    Cytotherapy; 2001; 3(3):135-6. PubMed ID: 12171720
    [No Abstract]   [Full Text] [Related]  

  • 9. Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease.
    Teshima T; Nagafuji K; Henzan H; Miyamura K; Takase K; Hidaka M; Miyamoto T; Takenaka K; Akashi K; Harada M
    Int J Hematol; 2009 Sep; 90(2):253-260. PubMed ID: 19543951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow transplantation for severe aplastic anaemia: cost/benefit of increased immunosuppression.
    Gordon-Smith EC
    Bone Marrow Transplant; 1991; 7 Suppl 2():103-5. PubMed ID: 1908725
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment of reactive arthritis with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
    Tanaka T; Kuwahara Y; Shima Y; Hirano T; Kawai M; Ogawa M; Arimitsu J; Hagihara K; Narazaki M; Ogata A; Kawase I; Kishimoto T
    Arthritis Rheum; 2009 Dec; 61(12):1762-4. PubMed ID: 19950316
    [No Abstract]   [Full Text] [Related]  

  • 12. Alemtuzumab for the treatment of steroid-refractory acute graft-versus-host disease.
    Gómez-Almaguer D; Ruiz-Argüelles GJ; del Carmen Tarín-Arzaga L; González-Llano O; Gutiérrez-Aguirre H; Cantú-Rodríguez O; Jaime-Pérez J; Carrasco-Yalán A; Giralt S
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):10-5. PubMed ID: 18158956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of a patient with remitting seronegative, symmetrical synovitis with pitting oedema with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
    Tanaka T; Hagihara K; Shima Y; Narazaki M; Ogata A; Kawase I; Kishimoto T
    Rheumatology (Oxford); 2010 Apr; 49(4):824-6. PubMed ID: 20008092
    [No Abstract]   [Full Text] [Related]  

  • 14. Daclizumab, an efficient treatment for steroid-refractory acute graft-versus-host disease.
    Bordigoni P; Dimicoli S; Clement L; Baumann C; Salmon A; Witz F; Feugier P
    Br J Haematol; 2006 Nov; 135(3):382-5. PubMed ID: 16984386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study on recombinant humanized anti-CD25 monoclonal antibody used for treating steroid-resistant acute graft versus host disease following allo-hematopoietic stem cell transplantation].
    Li XH; Gao CJ; DA WM; Cao YB; Xu LX; Wu YM; Liu B; Liu ZY; Yan B; Li SW; Yang XL; Wu XX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1535-40. PubMed ID: 24370044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excellent therapeutic effect of tocilizumab on intestinal amyloid a deposition secondary to active rheumatoid arthritis.
    Inoue D; Arima H; Kawanami C; Takiuchi Y; Nagano S; Kimura T; Shimoji S; Mori M; Tabata S; Yanagita S; Matsushita A; Nagai K; Imai Y; Takahashi T
    Clin Rheumatol; 2010 Oct; 29(10):1195-7. PubMed ID: 20229259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alemtuzumab-induced resolution of refractory cutaneous chronic graft-versus-host disease.
    Ruiz-Argüelles GJ; Gil-Beristain J; Magaña M; Ruiz-Delgado GJ
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):7-9. PubMed ID: 18158955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease.
    Canninga-van Dijk MR; van der Straaten HM; Fijnheer R; Sanders CJ; van den Tweel JG; Verdonck LF
    Blood; 2004 Oct; 104(8):2603-6. PubMed ID: 15251978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic steroid-refractory graft-versus-host disease with low-dose rituximab.
    von Bonin M; Oelschlägel U; Radke J; Stewart M; Ehninger G; Bornhauser M; Platzbecker U
    Transplantation; 2008 Sep; 86(6):875-9. PubMed ID: 18813113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute gastrointestinal graft-versus-host disease in pediatric patients: serum albumin on day 5 from initiation of therapy correlates with nonrelapse mortality and overall survival.
    Goussetis E; Paisiou A; Kitra V; Peristeri I; Vessalas G; Stefanaki K; Panayotou I; Giamaiou K; Kontou E; Kitzoni M; Dimopoulou MN; Karkelis S; Kafritsa Y; Rapsomaniki E; Papassotiriou I; Tsirigotis P; Roma E; Graphakos S
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1058-66. PubMed ID: 21073975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.